Medtronic is developing surgical robots and expects to start generating revenue in FY 2019.

Release date: 2016-07-06

According to Reuters, Bryan Hanson, head of Medtronic's minimally invasive treatment business group, said recently that Medtronic will launch surgical robots before FY 2019, and the first surgical robot will be on the Indian market.

Bryan Hanson, head of Medtronic's minimally invasive treatment business group

In a speech at Medtronic Investor Day, Hanson said that surgical robots will bring "substantial revenue" in FY 2019.

In robot-assisted surgery, the surgeon can use the computer to guide the robot's robotic arm for manipulation. This type of incision is smaller and is increasingly being used in prostate and hysterectomy compared to conventional surgery.

It is understood that after the listing, Medtronic will compete with Intuitive Surgical's Da Vinci robot, the only robot currently used on the market for abdominal surgery. In addition, competitors are expected to have Verb Surgical, which is developing a robot, and Verb is a startup jointly supported by Johnson & Johnson and Google.

Medtronic entered the field of surgical robots to reduce the costs associated with robotic surgery. Hanson said: "The current related costs are high. We will seek ways to clear the barriers in this regard."

Medtronic, based in Minneapolis, currently employs 150 people in surgical robotics, located in Massa, USA, Connecticut, Colorado, and Germany.

Medtronic products cover pacemakers, heart valves, spinal implants and more. On Medtronic Investment Day, Medtronic also announced plans to introduce hip and knee replacement devices as part of the hospital's orthopaedic solution.

It is reported that Medtronic has acquired a company called Responsive Orthopedics to produce these devices. It is expected that knee replacement equipment will be available in the first half of 2017, and hip replacement equipment will be available again in a year.

Source: Arterial Network

API Products

An active substance is the main active ingredient in a drug. Take a simple aspirin for example. Acetyl salicylic acid is synthesized through chemical process and purified to a specified purity. The synthesis of acetyl salicylic acid is made by adding various excipients, such as fillers, adhesives, disintegrating agents, etc., and then pressing it into tablets. The production of apis is generally either pure chemical synthesis, biological fermentation, or semi-synthesis, with biological fermentation followed by extraction followed by synthesis. Not all pharmaceutical enterprises make API by themselves, and many manufacturers do not have the scale to produce API. Even if there is large-scale production, the cost of production may be much higher than that of procurement. Therefore, most manufacturers buy bulk drugs, and then make preparations, so that the production of drugs can be completed without a very large scale. At present, China and India have become the two largest API producers in the world. Many European and American pharmaceutical companies, even some of their own original drugs, will give up the production of API as the patent expires and the market matures, and turn to purchase apis from China and India,API production generally go through laboratory, generated through laboratory bottle container canister, taking after successful, pilot magnification, which is to enlarge the quantity of the production, then no problem tends to be faced with a lot of small scale experiment, a very simple example, the heating process, due to the relatively small amount in the laboratory, uneven heating cases is less, But if it is scaled up to a few tons of pot, at this time the heating may be not hot in this place, where the paste pot, at this time you need to stir, but the speed of mixing is appropriate, this process needs to calculate or grope. Finally from the pilot test, and then to the formal production, the volume of further amplification, and will face a lot of new problems. Therefore, although some drugs are generic, the research and development of the whole process from small test, pilot test to the final mass production is indispensable, so even generic drugs have very high research and development costs.

api meaning,api products to buy,best api products,cheap api products,best buy products api,best api products

Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptide-nootropics.com